A double-blind placebo-controlled randomized clinical trial of fluvoxamine and sertraline in childhood autism - Does SSRI therapy improve behaviour and/or mood?

Trial Profile

A double-blind placebo-controlled randomized clinical trial of fluvoxamine and sertraline in childhood autism - Does SSRI therapy improve behaviour and/or mood?

Completed
Phase of Trial: Phase III

Latest Information Update: 02 May 2008

At a glance

  • Drugs Fluvoxamine (Primary) ; Sertraline (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top